RESMED (RME MU) stock market data APIs
€195.7315
0(0%)
as of September 23, 2026
Try our APIs with
free plan!
RESMED Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for RME.MU.
Prev. Close
195.7315
Open
195.7315
High
195.7315
Low
195.7315
52 wk Range
157.4877-240.3411
Market Cap
33 727 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get RESMED data using free add-ons & libraries
Get RESMED Fundamental Data
RESMED Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
RESMED News
New
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures
ResMed Inc. (NYSE:RMD) is well positioned to benefit from the long-term growth of the global obstructive sleep apnea (OSA) treatment market. Likewise, the company remains well positioned to benefit fr...
Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.
Sleep device maker ResMed rose Tuesday after the stock notched an upgrade and price target increase on Wall Street. RBC Capital analysts boosted the stock’s rating to Outperform from Sector Perfo...
Is Margin Pressure From Rising Costs Altering The Investment Case For ResMed (RMD)?
Earlier this year, ResMed reported quarterly results showing revenue of US$1.46 billion, up 8.6% year on year, with adjusted earnings per share ahead of expectations but accompanied by operating margi...
ResMed Projected to Attain High-Single-Digit EPS Growth in Next Three Years, RBC Says
ResMed (RMD) is projected to attain high-single-digit EPS growth over the next three years, despite PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
Get RESMED fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
